Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Heuser

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Pharmacopsychiatry|May 16, 2017
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?Rebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
Psychiatry Research|March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophreniaIlja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Dementia and Geriatric Cognitive Disorders|April 3, 2009
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence NetworkJohannes Kornhuber, Klaus Schmidtke, Lutz Frolich, et al.
Plos One|July 15, 2014
Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairmentSteffen Wolfsgruber, Michael Wagner, Klaus Schmidtke, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated formHans-Wolfgang Klafki, Piotr Lewczuk, Heike Kamrowski-Kruck, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's diseaseKatrin Morgen, Lutz Frölich, Heike Tost, et al.
Journal of Alzheimer'S Disease : JAD|October 21, 2015
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive ImpairmentAlexander Koppara, Steffen Wolfsgruber, Luca Kleineidam, et al.
Alzheimer'S Research & Therapy|October 12, 2017
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementiaLutz Frölich, Oliver Peters, Piotr Lewczuk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2014
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseKatrin Morgen, Alfredo Ramirez, Lutz Frölich, et al.
Alzheimer'S Research & Therapy|May 19, 2015
Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping studyKatrin Morgen, Michael Schneider, Lutz Frölich, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Pharmacopsychiatry|May 16, 2017
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?Rebecca Schennach, Michael Obermeier, Florian Seemüller, et al.
Psychiatry Research|March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophreniaIlja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Dementia and Geriatric Cognitive Disorders|April 3, 2009
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence NetworkJohannes Kornhuber, Klaus Schmidtke, Lutz Frolich, et al.
Plos One|July 15, 2014
Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairmentSteffen Wolfsgruber, Michael Wagner, Klaus Schmidtke, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated formHans-Wolfgang Klafki, Piotr Lewczuk, Heike Kamrowski-Kruck, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's diseaseKatrin Morgen, Lutz Frölich, Heike Tost, et al.
Journal of Alzheimer'S Disease : JAD|October 21, 2015
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive ImpairmentAlexander Koppara, Steffen Wolfsgruber, Luca Kleineidam, et al.
Alzheimer'S Research & Therapy|October 12, 2017
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementiaLutz Frölich, Oliver Peters, Piotr Lewczuk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2014
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseKatrin Morgen, Alfredo Ramirez, Lutz Frölich, et al.
Alzheimer'S Research & Therapy|May 19, 2015
Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping studyKatrin Morgen, Michael Schneider, Lutz Frölich, et al.
Pageof 20